SQLite Web: event

seq

Primary key. INTEGER

id

TEXT NOT NULL

kind

TEXT NOT NULL

ts

TEXT NOT NULL

actor

TEXT

subject_entity_ids

TEXT

payload

{"created_at":"2026-04-20T22:09:16.557188+00:00","signal_type":"news_headline_delta","source":"news_rss","url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPVG9fczBtWDhjbEZjTU5XaU8taG50MzFHNnhfVXhXa2NRSTdFbFVYWHdsampBUVlTb09JYjRKcmFXWWgzbEJjcDktWlNJeVJsM3d0RUh0aC1odjQtTEpiUFVFNXgxVzZ4R1JWbHJMbGh6ZEhjMzJ0TXEyd2dxNlVjRGFtcUdnX2luVUtR?oc=5","value":{"fp":"754cfa9e8821594d","published_at":"2026-04-20T16:05:59+00:00","source":"statnews.com","source_domain":"statnews.com","source_url":"https://www.statnews.com","summary":"Eli Lilly\u2019s $3.25 billion acquisition of Kelonia Therapeutics caps startup\u2019s tortuous ride statnews.com Lilly to buy Boston biotech Kelonia for $3.25 billion in latest Mass. investment The Boston Globe Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion CNBC Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies | Eli Lilly and Company investor.lilly.com Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says Yahoo","title":"Eli Lilly\u2019s $3.25 billion acquisition of Kelonia Therapeutics caps startup\u2019s tortuous ride - statnews.com","url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPVG9fczBtWDhjbEZjTU5XaU8taG50MzFHNnhfVXhXa2NRSTdFbFVYWHdsampBUVlTb09JYjRKcmFXWWgzbEJjcDktWlNJeVJsM3d0RUh0aC1odjQtTEpiUFVFNXgxVzZ4R1JWbHJMbGh6ZEhjMzJ0TXEyd2dxNlVjRGFtcUdnX2luVUtR?oc=5"}}

TEXT NOT NULL

source_ref

TEXT

confidence

REAL (default 0.0

dedupe_key

TEXT

episode_id

TEXT

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

event_store.db — events

Update row 465942 in events